Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000289073 | SCV000352420 | likely benign | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000344087 | SCV000352421 | likely benign | Age related macular degeneration 4 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000403698 | SCV000352422 | likely benign | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000309119 | SCV000352423 | likely benign | Basal laminar drusen | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Labcorp Genetics |
RCV001317993 | SCV001508679 | uncertain significance | not provided | 2025-01-22 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 650 of the CFH protein (p.Gly650Val). This variant is present in population databases (rs143237092, gnomAD 0.04%). This missense change has been observed in individual(s) with glomerulonephritis C3 or age-related macular degeneration (PMID: 17018561, 23852337, 29888403). ClinVar contains an entry for this variant (Variation ID: 294497). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change does not substantially affect CFH function (PMID: 34189567). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV001317993 | SCV002541406 | uncertain significance | not provided | 2021-04-28 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294228 | SCV002587654 | uncertain significance | Atypical hemolytic-uremic syndrome | 2021-05-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005003619 | SCV005630023 | uncertain significance | Basal laminar drusen; Factor H deficiency; Hemolytic uremic syndrome, atypical, susceptibility to, 1; Age related macular degeneration 4 | 2024-02-14 | criteria provided, single submitter | clinical testing |